Evidence map›Paper›PMID 20707868›Full record

ArticleBiometrics2011

Frailty-based competing risks model for multivariate survival data.

Malka Gorfine, Li Hsu

Abstract read
In one paragraph

Article in Biometrics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Optimizing natural killer cell doses for heterogeneous cancer patients on the basis of multiple event times.Journal of the Royal Statistical Society. Series C, Applied statistics · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Estimating State Transitions for Opioid Use Disorders.Medical decision making : an international journal of the Society for Medical Decision Making · 2017
    Article
  19. A Semi-parametric Transformation Frailty Model for Semi-competing Risks Survival Data.Scandinavian journal of statistics, theory and applications · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Malka GorfineFaculty of Industrial Engineering and Management, Technion-Israel Institute of Technology Technion City, Haifa 32000, Israel. gorfinm@ie.technion.ac.il
Li Hsu

Funding

Use of Biomarkers in Diagnosis, Prognosis, Risk Prediction and Early Detection ofP01CA053996 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HSU, LI · 1991 to 2015
$9.4M
Statistical Methods in Genetic EpidemiologyR01AG014358 · NIA · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HSU, LI · 2002 to 2013
$2.4M
NCI NIH HHS P01 CA053996NCI NIH HHS P01 CA53996NIA NIH HHS R01 AG014358NIA NIH HHS R01 AG14358
6 · The paper itself

Abstract

In this work, we provide a new class of frailty-based competing risks models for clustered failure times data. This class is based on expanding the competing risks model of Prentice et al. (1978, Biometrics 34, 541-554) to incorporate frailty variates, with the use of cause-specific proportional hazards frailty models for all the causes. Parametric and nonparametric maximum likelihood estimators are proposed. The main advantages of the proposed class of models, in contrast to the existing models, are: (1) the inclusion of covariates; (2) the flexible structure of the dependency among the various types of failure times within a cluster; and (3) the unspecified within-subject dependency structure. The proposed estimation procedures produce the most efficient parametric and semiparametric estimators and are easy to implement. Simulation studies show that the proposed methods perform very well in practical situations.

Indexed as

Multivariate AnalysisSurvival AnalysisCluster AnalysisComputer SimulationHumansLikelihood FunctionsRisk

Identifiers

PMID20707868
PMCPMC3138494

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.